ADVFN Logo
Boards:
    Quotes:
      Boards
      News
      Market Data
      Markets
      Discover
      Subscribe Login/Register Profile Icon
      S&P 500
      5,505.00
      -0.71%
      US Tech 100
      19,000.00
      -0.94%
      Dow Jones
      40,287.53
      -0.93%
      Brent Oil
      82.03
      -0.30%
      Bitcoin
      67,876.12
      -0.41%
      Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
      Get Started
      1. Home
      2. Investing
      3. Stocks
      4. USA
      5. NASDAQ

      6. Rani Therapeutics Holdings Inc (RANI) Quote

      Rani Therapeutics Holdings Inc

      Rani Therapeutics Holdings Inc (RANI)

      NASDAQ
      3.08
      -0.29
      (-8.61%)
      Closed July 21 4:00PM
      Delayed by 15 minutes
      3.05
      -0.03
      (-0.97%)
      After Hours: 7:59PM
      Delayed by 15 minutes

      Empower your portfolio: Real-time discussions and actionable trading ideas.

      Premium

      Key stats and details

      Current Price
      3.08
      Bid
      1.55
      Ask
      4.30
      Volume
      209,398
      3.01 Day's Range 3.84
      1.82 52 Week Range 8.75
      Market Cap
      169.916M
      Previous Close
      3.37
      Open
      3.30
      Last Trade
      3
      @
      3.23
      Last Trade Time
      Financial Volume
      $ 665,392
      VWAP
      3.1776
      Average Volume (3m)
      87,293
      Shares Outstanding
      50,420,315
      Dividend Yield
      -
      PE Ratio
      -4.53
      Earnings Per Share (EPS)
      -0.67
      Revenue
      -
      Net Profit
      -33.97M

      About Rani Therapeutics Holdings Inc

      Rani Therapeutics Holdings Inc is a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics. The company has developed the RaniPill capsule, a proprietary and patented platform technology, intended to replace subcutaneous or IV injecti... Rani Therapeutics Holdings Inc is a clinical stage biotherapeutics company advancing technologies to enable the development of orally administered biologics. The company has developed the RaniPill capsule, a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. Show more

      Sector
      Pharmaceutical Preparations
      Industry
      Pharmaceutical Preparations
      Website
      www.ranitherapeutics.com
      Headquarters
      Wilmington, Delaware, USA
      Founded
      1970
      Rani Therapeutics Holdings Inc is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker RANI. The last closing price for Rani Therapeutics was $3.37. Over the last year, Rani Therapeutics shares have traded in a share price range of $ 1.82 to $ 8.75.

      Rani Therapeutics currently has 50,420,315 shares outstanding. The market capitalization of Rani Therapeutics is $169.92 million. Rani Therapeutics has a price to earnings ratio (PE ratio) of -4.53.

      RANI Latest News

      More News

      Form 8-K - Current report

      July 12 2024
      Edgar (US Regulatory)

      Rani Therapeutics Announces Partnership with ProGen on Development of Oral Obesity Treatment

      ~ New RT-114 obesity program combines ProGen’s FC Fusion protein conjugated GLP-1/GLP-2 dual agonist, PG-102, with the RaniPill® capsule designed to provide a differentiated oral delivery...

      June 24 2024
      GlobeNewswire Inc.

      Form 8-K - Current report

      May 30 2024
      Edgar (US Regulatory)

      Rani Therapeutics to Participate in May Investor Conferences

      SAN JOSE, Calif., May 14, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...

      May 14 2024
      GlobeNewswire Inc.

      Rani Therapeutics to Present Clinical and Preclinical Data on Oral Delivery of an Ustekinumab Biosimilar via the RaniPill® Capsule at Digestive Disease Week 2024

      SAN JOSE, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...

      May 09 2024
      GlobeNewswire Inc.

      Form 10-Q - Quarterly report [Sections 13 or 15(d)]

      May 06 2024
      Edgar (US Regulatory)

      Rani Therapeutics Reports First Quarter 2024 Financial Results; Provides Corporate Update

      - Announced Positive Topline Results from Phase 1 Study of an Oral Anti-Interleukin 12/23 Antibody (RT-111) - - Initiation of Phase 2 clinical trial for RT-102 for the treatment of osteoporosis...

      May 06 2024
      GlobeNewswire Inc.

      Form 8-K - Current report

      May 06 2024
      Edgar (US Regulatory)

      Rani Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results; Provides Corporate Update

      - Announced Positive Topline Results from Phase 1 Study of an Oral Anti-Interleukin 12/23 Antibody (RT-111) - - Announced Preclinical Pharmacodynamic Data on Transenteric Delivery of GLP-1...

      March 20 2024
      GlobeNewswire Inc.

      Rani Therapeutics to Report Fourth Quarter and Full Year 2023 Financial Results

      SAN JOSE, Calif., March 15, 2024 (GLOBE NEWSWIRE) -- Rani Therapeutics Holdings, Inc. (“Rani Therapeutics” or “Rani”) (Nasdaq: RANI), a clinical-stage biotherapeutics company focused on the oral...

      March 15 2024
      GlobeNewswire Inc.
      PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
      1-0.52-14.44444444443.64.193.01651223.83322511CS
      4-0.99-24.32432432434.074.373.01499163.82499114CS
      12-3.4-52.46913580256.487.883.01872935.49202516CS
      26-0.42-123.58.752.851083745.20976858CS
      52-1.11-26.4916467784.198.751.82902534.27052072CS
      156-8.18-72.646536412111.2636.271.828457710.93343404CS
      260-8.18-72.646536412111.2636.271.828457710.93343404CS

      Movers

      View all
      • Most Active
      • % Gainers
      • % Losers
      SymbolPriceVol.
      SERVServe Robotics Inc
      $ 7.51
      (185.55%)
      		266.26M
      AUGXAugmedix Inc
      $ 2.27
      (147.71%)
      		24.14M
      XCURExicure Inc
      $ 0.5351
      (76.02%)
      		14.02M
      PSNLPersonalis Inc
      $ 3.83
      (56.33%)
      		22.8M
      MDBHMDB Capital Holdings LLC
      $ 10.675
      (37.21%)
      		126.45k
      SPWRSunPower Corporation
      $ 0.6735
      (-55.40%)
      		119.98M
      HYZNHyzon Motors Inc
      $ 0.149
      (-47.54%)
      		23.37M
      MEDSTRxADE Health Inc
      $ 14.92
      (-33.45%)
      		204.34k
      SILOSilo Pharma Inc
      $ 2.50
      (-27.95%)
      		11.12M
      KITTNauticus Robotics Inc
      $ 0.0935
      (-27.46%)
      		26.52M
      SERVServe Robotics Inc
      $ 7.51
      (185.55%)
      		266.26M
      SXTP60 Degrees Pharmaceuticals Inc
      $ 0.2602
      (5.77%)
      		226.82M
      NVDANVIDIA Corporation
      $ 117.93
      (-2.61%)
      		217.11M
      SQQQProShares UltraPro Short QQQ
      $ 8.46
      (2.79%)
      		188.2M
      SPWRSunPower Corporation
      $ 0.6735
      (-55.40%)
      		124.61M

      RANI Discussion

      View Posts
      PonkenPlonken PonkenPlonken 2 months ago
      MGRX did 330% today on news of planning to distribute an oral version of GLP1 sometime in the future.
      This company has the platform to produce a promising oral GLP1 option right now.

      You also get some free shots at the goal in 4 other indications.
      👍️0
      Monksdream Monksdream 3 months ago
      RANI under $10
      👍️0
      PonkenPlonken PonkenPlonken 3 months ago
      wants sooo much more
      👍️0
      PonkenPlonken PonkenPlonken 3 months ago
      shake shake the tree
      👍️0
      TrendTrade2016 TrendTrade2016 3 months ago
      RANI...HERE COMES 9.00...LOL
      👍️0
      TrendTrade2016 TrendTrade2016 3 months ago
      RANI...8 DOLLA FLOOR BEING BUILT
      👍️0
      TrendTrade2016 TrendTrade2016 3 months ago
      RANI 8 DOLLA...FORTUNE COOKIE WAS RIGHT....LMAO
      👍️0
      TrendTrade2016 TrendTrade2016 3 months ago
      RANI...LETS SEE 8 BUCKS
      👍️0
      TrendTrade2016 TrendTrade2016 3 months ago
      SOMEONE WITH BRAINS AROUND HERE
      👍️ 1
      TrendTrade2016 TrendTrade2016 3 months ago
      RANI...GAPPING TO 7.50...LMAO...WHAT A CALL FROM THE HOUSE OF TREND
      👍️0
      PonkenPlonken PonkenPlonken 3 months ago
      $RANI can clear worries about GLP adm.
      No sellers in consecutive sessions.
      👍️0
      TrendTrade2016 TrendTrade2016 3 months ago
      ITS RAINING AGAIN WITH RANI...IS TIM ON THIS ONE?!!
      👍️0
      TrendTrade2016 TrendTrade2016 3 months ago
      RANI...LET THEM CHASE THE ALGO FABRICATIONS WHILE WE WATCH RANI TREND TO 7.00
      👍️0
      TrendTrade2016 TrendTrade2016 3 months ago
      RANI...HERE COMES 7.00
      👍️0
      TrendTrade2016 TrendTrade2016 3 months ago
      RANI...BREAKING NEW HIGH
      👍️0
      TrendTrade2016 TrendTrade2016 3 months ago
      RANI...BREAKING 6.00...BIO BEAST!!!
      👍️0
      TrendTrade2016 TrendTrade2016 3 months ago
      RANI...ITS RAINING AGAIN
      👍️0
      TrendTrade2016 TrendTrade2016 3 months ago
      RANI...HERE WE GO
      👍️0
      TrendTrade2016 TrendTrade2016 3 months ago
      RANI....BIO MONSTER
      👍️0
      TrendTrade2016 TrendTrade2016 3 months ago
      RANI...THIN AS THIN...ARCA BID
      👍️0
      TrendTrade2016 TrendTrade2016 3 months ago
      RANI...NEXT BIO BEAST READY TO BEAST
      👍️0

      Your Recent History

      NASDAQ
      RANI
      Rani Therapeutics
      Delayed Upgrade Clock